Vanda Pharmaceuticals (NASDAQ:VNDA) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $18.00 target price on shares of Vanda Pharmaceuticals in a research note on Monday, December […]
More Stories
What is Snapchat Planet Order? Meaning, Origin, and More Details
Snapchat is one of the most widely used social media platforms. It stands neck to neck with other popular social...
Is The Amazing Digital Circus Renewed? Know about its Release Date
Are you also a fan of adult anime shows? Good news, everyone’s favourite fantasy drama, The Amazing Digital Circus, aka...
Tex Mex Motors Season 3 Updates and Renewal Details
The 2023 premiere series, Tex Mex Motors, is a reality TV show. The series has 2 seasons with episodes showing...
Grown Ups 3: Release Date, Cast Members, and Trailer Updates
About 16 years after its release, the comedy film Grown Ups is finally getting a sequel. The famous group of...
Ripe for the Picking Season 2: Release Date, Cast, and More
Ripe for the Picking is a Japanese manga series. It was first released as a magazine before becoming a web...
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...